RPS25 and neurodegenerative disease: In contrast, one study confirmed that RPS25 is a therapeutic target for neurodegenerative diseases caused by nucleotide repeat amplification, which indirectly confirms the role of RPS25 in the pathophysiological process of AD (Yamada et al., 2019).